title: Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal.
authors.affiliation: Department of Surgery, University of Chicago, IL 60637, USA.
authors.forename: D C
authors.initials: DC
authors.lastname: Cronin
authors.forename: D S
authors.initials: DS
authors.lastname: Bruce
authors.forename: K A
authors.initials: KA
authors.lastname: Newell
authors.forename: M A
authors.initials: MA
authors.lastname: Josephson
authors.forename: J M
authors.initials: JM
authors.lastname: Millis
authors.forename: J B
authors.initials: JB
authors.lastname: Piper
authors.forename: M
authors.initials: M
authors.lastname: Ruebe
authors.forename: M
authors.initials: M
authors.lastname: Kirby
authors.forename: J R
authors.initials: JR
authors.lastname: Thistlethwaite
authors.forename: E S
authors.initials: ES
authors.lastname: Woodle
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors; D014184:Transplantation, Homologous
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D003404:Creatinine; D011241:Prednisone; D016559:Tacrolimus